11/8/2024Bayer China Launches OPERA 2.0 Healthcare Platform

11/8/2024Recent Executive Moves

11/7/2024A Share-Listed Pharma Companies Report Solid Performance in Q3/2024

11/7/2024CDE Issues the Notice on the Technical Requirements for Pilot Registra...

11/7/2024CStone Announces Patent Publication for First-in-Class ADC CS5006

11/7/2024AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designation...

11/7/2024Minghui Pharma Announces Promising Initial Results from Phase I Trial ...

11/7/2024Aditum Bio and Leads Biolabs Forms JV Oblenio Bio to Develop a Tri-Spe...

11/7/2024Pfizer Unveils $1B 'China 2030 Strategy' at CIIE to Advance Innovation...

11/7/2024Stimulus Package vs. Drug Price Negotiation, Impacts on China's Health...

11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas

11/6/2024Shenyang Biotech Secures Pre-A Series Funding to Advance Peptide Vacci...

11/6/2024Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...

11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...

11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE

11/6/2024Novartis Highlights Commitment to China's Market at CIIE

11/6/2024Innovent Cancels 20% Stake Sale Amid Investor Concerns

11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...

11/5/2024Aurobindo Challenges China in the Global Penicillin G Market with New ...

11/5/2024NMPA Solicits Public Comments on Drug Contract Manufacturing Document

11/5/2024AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...

11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval

11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...

11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...

11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...

11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...

11/4/2024Big Pharma Doubles Down on China (The Wire China)

11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses

11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...

11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...

Page:52/786 Total number of articles:23558: [First][<<] [50] [51] [52] [53] [54] [>>] [End]